Alliance Data Systems Corporation (ADS) – Citron Short Thesis
Alliance Data Systems Corporation (NYSE:ADS): If You Don’t Like The Answer, Just Change The Question! by Citron Research
Alliance Data Systems Corporation (NYSE:ADS): If You Don’t Like The Answer, Just Change The Question! by Citron Research
If you are interested in contributing to ValueWalk on a regular or one time basis read this post http://www.valuewalk.com/guest-posts-hedge-fund-letters/ We do not accept any outside posts or even ads on penny stocks, ICOs, cryptos, forex, binary options and related products.
Notes of Andy Brough, the fund manager of Schroder Investment Management, from the 2018 London Sohn Conference. Check out more notes from the Sohn Conference below. Drew Dickson, Buy This... Read More
Saudi Arabia was the first oil-dependant economy to announce major budget changes following the collapse in the price of the commodity, and now Norway has followed suit. According to news... Read More
Yahoo! Inc. (NASDAQ:YHOO) released its earnings report for the three months ended September 30 this afternoon after the market close. The company showed earnings of $0.34 per share on... Read More
Crispin Odey has never liked central bank quantitative magic, saying an asset bubble was being created that would likely burst. The bearish London-based hedge fund manager, in a letter... Read More
The global COVID-19 outbreak has already had a "profound effect" on society, and many of the changes it has brought are "likely to reverberate through our economy for a... Read More
One effect of the 2013 bull market was that it left defined benefit corporate pensions in the best financial shape in years, but by the end of 2014 those... Read More
It’s that time of the year again. Over the past few weeks, the world's largest hedge funds have been filing their fourth-quarter 13Fs with the SEC. Below is a... Read More
Seth Klarman is one of the greatest value investors alive today. Over the past few decades, his hedge fund, the Boston-based Baupost, which manages around $30 billion of assets... Read More
Generic drug maker Actavis Inc (NYSE:ACT) is reported to have spurned a $15 billion cash and stock acquisition offer from Mylan Inc. (NASDAQ:MYL). According to Bloomberg, Actavis Inc (NYSE:ACT) would decide... Read More
More gloom than boom expected at WEF by Matthew Allen, swissinfo.ch January 22, 2014 - 11:00 In the afterglow of impressive stock market gains in 2013 and upbeat economic growth forecasts this year, the... Read More